REGENXBIO director granted RSUs and options
REGENXBIO Inc. director Jean Bennett received new equity awards as part of compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
REGENXBIO Inc. director Jean Bennett received new equity awards as part of compensation. She was granted 9,807 shares of common stock in the form of a time-based restricted stock unit (RSU) award, bringing her total direct holdings to 28,861 common shares.
She was also granted stock options covering 46,600 shares of common stock at an exercise price of $7.01 per share. Both the RSU and the option award are scheduled to vest on May 29, 2027, subject to her continuous service with REGENXBIO. The options expire on May 29, 2036.
Insider Trade Summary
Grant/Award: 56,407 shares
Grant/Award
2 txns
Insider
Bennett Jean
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 46,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,807 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 46,600 contracts (Direct);
Common Stock — 28,861 shares (Direct)
Footnotes (2)
- F1. Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer.
- F2. The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.
Key Figures
RSU shares granted: 9,807 shares
Options granted: 46,600 options
Option exercise price: $7.01 per share
+3 more
6 metrics
RSU shares granted
9,807 shares
Time-based restricted stock unit award to director Jean Bennett
Options granted
46,600 options
Stock options (right to buy) underlying common stock
Option exercise price
$7.01 per share
Strike price for 46,600 stock options
Shares held after grant
28,861 shares
Total direct common stock holdings following RSU award
Vesting date
May 29, 2027
Vesting for both RSU and stock option awards
Option expiration
May 29, 2036
Expiration date for 46,600 stock options
Key Terms
restricted stock unit, Stock Options (Right to Buy), exercise price, vesting, +1 more
5 terms
restricted stock unit financial
"Represents shares of common stock underlying a time-based restricted stock unit award (RSU)."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with an exercise price of 7.0100."
exercise price financial
"conversion_or_exercise_price: "7.0100" for the stock options grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The option will vest on May 29, 2027 and has an expiration date of May 29, 2036."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did REGENXBIO (RGNX) director Jean Bennett receive?
Jean Bennett received a grant of 9,807 common shares via a restricted stock unit award and stock options on 46,600 shares. These awards represent compensation rather than open-market purchases and are tied to continued service with REGENXBIO.
What are the vesting terms of Jean Bennett’s new REGENXBIO (RGNX) RSUs?
The 9,807-share restricted stock unit award vests 100% on May 29, 2027, if Jean Bennett continues serving REGENXBIO until that date. Until vesting, the RSUs represent a right to receive shares rather than currently issued, unrestricted stock.
What are the key terms of Jean Bennett’s new REGENXBIO (RGNX) stock options?
Jean Bennett was granted options on 46,600 REGENXBIO common shares at an exercise price of $7.01 per share. These options vest on May 29, 2027, subject to continuous service, and expire on May 29, 2036, if not exercised earlier.
Are Jean Bennett’s recent REGENXBIO (RGNX) transactions open-market buys or sales?
The transactions are equity compensation awards, not open-market trades. They consist of a restricted stock unit grant for 9,807 shares and stock options for 46,600 shares, both awarded at no cash cost to her on the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
